2008
DOI: 10.1016/j.cell.2008.06.037
|View full text |Cite
|
Sign up to set email alerts
|

Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases

Abstract: Summary Loss-of-function diseases are often caused by a mutation in a protein traversing the secretory pathway that compromises the normal balance between protein folding, trafficking and degradation. We demonstrate that the innate cellular protein homeostasis, or proteostasis, capacity can be enhanced to fold mutated enzymes that would otherwise misfold and be degraded, using small molecule proteostasis regulators. Two proteostasis regulators are reported that alter the composition of the proteostasis network… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

18
408
1
4

Year Published

2009
2009
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 330 publications
(431 citation statements)
references
References 56 publications
(106 reference statements)
18
408
1
4
Order By: Relevance
“…These are promising results considering that up to date, two different approaches aimed to enhance protein stability and prevent mutant protein degradation, have been successfully assessed in other models of misfolding diseases, such as cystic fibrosis disease and Gaucher: the use of pharmacological chaperons (Alfonso et al 2005) and the use of molecules that enhance the innate cellular protein homeostasis (Wang et al 2006;Mu et al 2008). Although molecules that may function as pharmacological chaperones for NPC1 protein need to be identified and the usefulness of these therapeutic approaches needs to be assessed in NPC cells, our data strongly suggest that, at least some NPC1 patients may benefit from these kind of therapeutic strategies.…”
Section: Discussionmentioning
confidence: 99%
“…These are promising results considering that up to date, two different approaches aimed to enhance protein stability and prevent mutant protein degradation, have been successfully assessed in other models of misfolding diseases, such as cystic fibrosis disease and Gaucher: the use of pharmacological chaperons (Alfonso et al 2005) and the use of molecules that enhance the innate cellular protein homeostasis (Wang et al 2006;Mu et al 2008). Although molecules that may function as pharmacological chaperones for NPC1 protein need to be identified and the usefulness of these therapeutic approaches needs to be assessed in NPC cells, our data strongly suggest that, at least some NPC1 patients may benefit from these kind of therapeutic strategies.…”
Section: Discussionmentioning
confidence: 99%
“…Since the proteostasis network encompasses a wide range of key proteins involved in different steps in protein biogenesis, maintenance (folding and refolding), trafficking and degradation, both activators and inhibitors have been screened to affect each of these individual steps. A combination of chemical and biological approaches can be used to rebalance the cellular proteostasis capacity under stress conditions and therefore hold a great therapeutic potential to treat several human diseases including protein conformational disorders and cancer (Lindquist and Kelly, 2011;Mu et al, 2008;Powers et al, 2009). …”
Section: Ii45 Small Molecule Regulators Of Proteostasismentioning
confidence: 99%
“…In a recent study, it was shown that administration of PR such as celastrol or MG132 increase the unfolded protein response (UPR) resulting in the coordinated transcription and translation of chaperones and folding catalysts that promote folding of mutant enzyme in the ER and prevent it from misfolding/aggregation. The co-administration of PC stabilizes the folded state of mutant enzyme and synergizes with PR to effectively rescue the loss-of-function phenotype of the enzyme (Mu et al, 2008). Therefore, it seems possible that a combination therapy of highly specific PR and PC can be useful to treat protein conformational disorders.…”
Section: Ii45 Small Molecule Regulators Of Proteostasismentioning
confidence: 99%
See 1 more Smart Citation
“…20 Several studies have involved in vitro studies coupled with computer simulations, [20][21][22][23] and many others have been concerned with the goal of relating processes studied in atomic detail in the test tube to their quantitative effects in living systems. [24][25][26] Moreover, recent findings suggest that further developments in this area could have much more general relevance to understanding the way in which well-established physical and chemical principles can provide new insights into the apparent complexity of biology. 27 The discovery of the common existence of amyloid and amyloid-like states is of unique importance in understanding the nature of biological systems because it reveals that there is an alternative stable and highly ordered state, accessible essentially to all proteins, in addition to the native one; 10,28,29 this observation has profound implications in diverse fields ranging from medicine to materials science.…”
Section: Introductionmentioning
confidence: 99%